Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

PainChek Ltd (PCK) Share Price & Analysis

15 Followers

PCK Stock Chart & Stats

A$0.07A$0.00(2.94%)
At close: 4:00 PM GMT+11
AU$0.075AU$0.1AU$0.125Aug 10Aug 24Sep 7Sep 21Oct 6Oct 19Nov 2
Day’s Range
AUD 0.07 - AUD 0.07
52-Week Range
AUD 0.07 - AUD 0.48
Previous Close
AUD 0.07
Volume
N/A
Average Volume (3M)
182.80K
Market Cap
AUD 14.23M
Enterprise Value
AUD 21.59M
Total Cash (Recent Filing)
AUD 5.99M
Total Debt (Recent Filing)
AUD 4.25M
Price to Earnings (P/E)
―
Beta
1.17
Next Earnings
Mar 03, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Rapid Revenue Growth

Rapid and sustained revenue expansion indicates that PainChek is increasing adoption of its digital assessment solutions. Continued top-line growth can improve operating leverage over time, broaden its provider base, and create a larger platform from which future profitability may develop.

Improving Gross Margin

The substantial gross-margin improvement suggests stronger unit economics and a more attractive revenue model than in the prior year. If maintained as revenue scales, higher gross profitability should allow more of each additional dollar of sales to support operating costs and eventual breakeven.

Specialised Digital Pain Assessment

PainChek addresses a defined clinical problem in aged care and healthcare by helping providers identify, monitor, and document pain when patients cannot reliably communicate it. This specialised software focus supports a clear use case and recurring relevance for care delivery.

Bears Say

Deep Ongoing Losses

The scale of ongoing losses shows that revenue growth and improved gross margin have not yet covered the company’s operating cost base. Without a visible path to breakeven, PainChek remains exposed to prolonged earnings pressure and may need substantial execution improvement to become self-sustaining.

Persistent Cash Burn

Heavy and worsening operating cash outflows indicate that the business is not currently funding itself through operations. Persistent negative free cash flow can constrain investment flexibility and increase reliance on capital raises or new financing to maintain growth and meet ongoing obligations.

Stressed Capital Structure

Negative equity combined with newly added debt materially reduces financial flexibility and increases reliance on external funding. This stressed structure leaves less capacity to absorb further losses, support expansion internally, or manage obligations without additional financing or balance-sheet repair.

PainChek Ltd News

PCK FAQ

What was PainChek Ltd’s price range in the past 12 months?
PainChek Ltd lowest share price was AU$0.07 and its highest was AU$0.48 in the past 12 months.
What is PainChek Ltd’s market cap?
PainChek Ltd’s market cap is AU$14.23M.
When is PainChek Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PainChek Ltd’s earnings last quarter?
PainChek Ltd released its earnings results on Sep 22, 2026. The company reported -AU$0.02 earnings per share for the quarter.
Is PainChek Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PainChek Ltd pay dividends?
PainChek Ltd does not currently pay dividends.
What is PainChek Ltd’s EPS estimate?
PainChek Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PainChek Ltd have?
PainChek Ltd has 209,249,440 shares outstanding.
What happened to PainChek Ltd’s price movement after its last earnings report?
PainChek Ltd reported an EPS of -AU$0.02 in its last earnings report. Following the earnings report the stock price went down -4.545%.
Which hedge fund is a major shareholder of PainChek Ltd?
Currently, no hedge funds are holding shares in AU:PCK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology